Exsil 300 Hexyl

Wide-Pore C6 Phase for Enhanced Selectivity in Protein and Peptide HPLC

Exsil 300 Hexyl is a high-performance wide-pore (300 Å) silica stationary phase featuring a hexyl (C6) bonded surface, specifically designed for reversed-phase HPLC separations of proteins, peptides, and other large biomolecules. The C6 functionalization provides intermediate hydrophobic retention, positioned between C4 and C8 phases, offering optimized selectivity and controlled elution behavior for complex biological samples.

The 300 Å pore size ensures full accessibility of macromolecules, enabling efficient mass transfer and minimizing steric hindrance. This results in high resolution, sharp peak symmetry, and reproducible retention times, even for larger peptides and small to medium-sized proteins. The balanced hydrophobic interaction of the hexyl chain improves separation of structurally related biomolecules while maintaining high recovery. Exsil 300 Hexyl is manufactured from uniform, spherical high-purity silica, delivering excellent mechanical stability, consistent packing behavior, and long column lifetime. The phase performs reliably under gradient conditions and is fully compatible with common reversed-phase mobile phases, including aqueous/organic mixtures with TFA or formic acid modifiers.

Exsil 300 Hexyl combines wide-pore accessibility with optimized C6 hydrophobic selectivity – the dependable solution for high-resolution, reproducible reversed-phase separations of complex biomolecules.

Key Features

  • 300 Å wide-pore silica optimized for proteins and peptides

  • Hexyl (C6) bonded phase with intermediate hydrophobic retention

  • Excellent mass transfer for high-molecular-weight analytes

  • High efficiency, reproducibility, and stable retention behavior

  • Robust spherical particles for reliable analytical and preparative use

  • Ideal for gradient reversed-phase HPLC applications

Typical Applications

  • Reversed-phase HPLC of peptides and small to medium proteins

  • Biomolecule characterization in pharmaceutical and biotech laboratories

  • Method development requiring selectivity between C4 and C8 phases

  • QC analysis of therapeutic peptides and protein fragments

Specifications

Request Product
Particle Size
  • 3 µm
Pore Size 300 Å
Surface Area 100 m²/g
Phase/Modification C6
Particle Type
Separation Mode
USP Code
Endcapping Yes
Carbonload 4 %
pH Range 2 - 8

Material Number

Phase Material Number
Exsil 300 Hexyl, 3 µm 5136814.
Exsil 300 Butyl Exsil 300 Octyl

Any questions?
We are here to help you.

info@dr-maisch.com +49 7073 5035 7

Follow us